Table of Contents Executive Summary 1 Industry Overview of Acromegaly and Gigantism Drugs 1.1 Definition of Acromegaly and Gigantism Drugs 1.2 Acromegaly and Gigantism Drugs Segment by Type 1.2.1 Global Acromegaly and Gigantism Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Somatostatin Analogs 1.2.3 GH Receptor Antagonists 1.2.4 Dopamine Agonists 1.2.5 Recombinant Human IGF-1 1.3 Acromegaly and Gigantism Drugs Segment by Applications 1.3.1 Global Acromegaly and Gigantism Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Acromegaly and Gigantism Drugs Overall Market 1.4.1 Global Acromegaly and Gigantism Drugs Revenue (2014-2025) 1.4.2 Global Acromegaly and Gigantism Drugs Production (2014-2025) 1.4.3 North America Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 1.4.4 Europe Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 1.4.5 China Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 1.4.6 Japan Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 1.4.8 India Acromegaly and Gigantism Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Acromegaly and Gigantism Drugs 2.3 Manufacturing Process Analysis of Acromegaly and Gigantism Drugs 2.4 Industry Chain Structure of Acromegaly and Gigantism Drugs 3 Development and Manufacturing Plants Analysis of Acromegaly and Gigantism Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Acromegaly and Gigantism Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Acromegaly and Gigantism Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Acromegaly and Gigantism Drugs Production and Capacity Analysis 4.2 Acromegaly and Gigantism Drugs Revenue Analysis 4.3 Acromegaly and Gigantism Drugs Price Analysis 4.4 Market Concentration Degree 5 Acromegaly and Gigantism Drugs Regional Market Analysis 5.1 Acromegaly and Gigantism Drugs Production by Regions 5.1.1 Global Acromegaly and Gigantism Drugs Production by Regions 5.1.2 Global Acromegaly and Gigantism Drugs Revenue by Regions 5.2 Acromegaly and Gigantism Drugs Consumption by Regions 5.3 North America Acromegaly and Gigantism Drugs Market Analysis 5.3.1 North America Acromegaly and Gigantism Drugs Production 5.3.2 North America Acromegaly and Gigantism Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Acromegaly and Gigantism Drugs Import and Export 5.4 Europe Acromegaly and Gigantism Drugs Market Analysis 5.4.1 Europe Acromegaly and Gigantism Drugs Production 5.4.2 Europe Acromegaly and Gigantism Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Acromegaly and Gigantism Drugs Import and Export 5.5 China Acromegaly and Gigantism Drugs Market Analysis 5.5.1 China Acromegaly and Gigantism Drugs Production 5.5.2 China Acromegaly and Gigantism Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Acromegaly and Gigantism Drugs Import and Export 5.6 Japan Acromegaly and Gigantism Drugs Market Analysis 5.6.1 Japan Acromegaly and Gigantism Drugs Production 5.6.2 Japan Acromegaly and Gigantism Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Acromegaly and Gigantism Drugs Import and Export 5.7 Southeast Asia Acromegaly and Gigantism Drugs Market Analysis 5.7.1 Southeast Asia Acromegaly and Gigantism Drugs Production 5.7.2 Southeast Asia Acromegaly and Gigantism Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Acromegaly and Gigantism Drugs Import and Export 5.8 India Acromegaly and Gigantism Drugs Market Analysis 5.8.1 India Acromegaly and Gigantism Drugs Production 5.8.2 India Acromegaly and Gigantism Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Acromegaly and Gigantism Drugs Import and Export 6 Acromegaly and Gigantism Drugs Segment Market Analysis (by Type) 6.1 Global Acromegaly and Gigantism Drugs Production by Type 6.2 Global Acromegaly and Gigantism Drugs Revenue by Type 6.3 Acromegaly and Gigantism Drugs Price by Type 7 Acromegaly and Gigantism Drugs Segment Market Analysis (by Application) 7.1 Global Acromegaly and Gigantism Drugs Consumption by Application 7.2 Global Acromegaly and Gigantism Drugs Consumption Market Share by Application (2014-2019) 8 Acromegaly and Gigantism Drugs Major Manufacturers Analysis 8.1 Ipsen 8.1.1 Ipsen Acromegaly and Gigantism Drugs Production Sites and Area Served 8.1.2 Ipsen Product Introduction, Application and Specification 8.1.3 Ipsen Acromegaly and Gigantism Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Novartis 8.2.1 Novartis Acromegaly and Gigantism Drugs Production Sites and Area Served 8.2.2 Novartis Product Introduction, Application and Specification 8.2.3 Novartis Acromegaly and Gigantism Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Pfizer 8.3.1 Pfizer Acromegaly and Gigantism Drugs Production Sites and Area Served 8.3.2 Pfizer Product Introduction, Application and Specification 8.3.3 Pfizer Acromegaly and Gigantism Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 9 Development Trend of Analysis of Acromegaly and Gigantism Drugs Market 9.1 Global Acromegaly and Gigantism Drugs Market Trend Analysis 9.1.1 Global Acromegaly and Gigantism Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Acromegaly and Gigantism Drugs Regional Market Trend 9.2.1 North America Acromegaly and Gigantism Drugs Forecast 2019-2025 9.2.2 Europe Acromegaly and Gigantism Drugs Forecast 2019-2025 9.2.3 China Acromegaly and Gigantism Drugs Forecast 2019-2025 9.2.4 Japan Acromegaly and Gigantism Drugs Forecast 2019-2025 9.2.5 Southeast Asia Acromegaly and Gigantism Drugs Forecast 2019-2025 9.2.6 India Acromegaly and Gigantism Drugs Forecast 2019-2025 9.3 Acromegaly and Gigantism Drugs Market Trend (Product Type) 9.4 Acromegaly and Gigantism Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Acromegaly and Gigantism Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Acromegaly and Gigantism Drugs Table Global Acromegaly and Gigantism Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Acromegaly and Gigantism Drugs Production Market Share by Types in 2018 Figure Somatostatin Analogs Product Picture Figure GH Receptor Antagonists Product Picture Figure Dopamine Agonists Product Picture Figure Recombinant Human IGF-1 Product Picture Table Global Acromegaly and Gigantism Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Acromegaly and Gigantism Drugs Consumption Market Share by Applications in 2018 Figure Hospitals Figure Clinics Figure Others Figure Global Acromegaly and Gigantism Drugs Revenue (Million USD) (2014-2025) Figure Global Acromegaly and Gigantism Drugs Production (K Units) (2014-2025) Figure North America Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Figure Europe Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Figure China Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Figure Japan Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Figure India Acromegaly and Gigantism Drugs Market Size (Million USD) (2014-2025) Table Acromegaly and Gigantism Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Acromegaly and Gigantism Drugs in 2018 Figure Manufacturing Process Analysis of Acromegaly and Gigantism Drugs Figure Industry Chain Structure of Acromegaly and Gigantism Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Acromegaly and Gigantism Drugs Manufacturing Plants Distribution Table Acromegaly and Gigantism Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Acromegaly and Gigantism Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table Acromegaly and Gigantism Drugs Production (K Units) of Major Manufacturers (2014-2019) Table Acromegaly and Gigantism Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Acromegaly and Gigantism Drugs Production Share by Manufacturers in 2018 Table Acromegaly and Gigantism Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Acromegaly and Gigantism Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Acromegaly and Gigantism Drugs Revenue Share by Manufacturers in 2018 Table Acromegaly and Gigantism Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Acromegaly and Gigantism Drugs Production by Regions 2014-2019 (K Units) Table Global Acromegaly and Gigantism Drugs Production Market Share by Regions 2014-2019 Figure Global Acromegaly and Gigantism Drugs Production Market Share by Regions in 2018 Table Global Acromegaly and Gigantism Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Acromegaly and Gigantism Drugs Revenue Market Share by Regions 2014-2019 Figure Global Acromegaly and Gigantism Drugs Revenue Market Share by Regions in 2018 Table Global Acromegaly and Gigantism Drugs Consumption by Regions 2014-2019 (K Units) Table Global Acromegaly and Gigantism Drugs Consumption Market Share by Regions 2014-2019 Figure North America Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure North America Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure Europe Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure China Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure China Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure Japan Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure India Acromegaly and Gigantism Drugs Production Growth Rate 2014-2019 (K Units) Figure India Acromegaly and Gigantism Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Acromegaly and Gigantism Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption Acromegaly and Gigantism Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Acromegaly and Gigantism Drugs Market Share by Application (2014-2019) Table Ipsen Acromegaly and Gigantism Drugs Production Sites and Area Served Table Ipsen Acromegaly and Gigantism Drugs Product Introduction, Application and Specification Table Ipsen Acromegaly and Gigantism Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Ipsen Acromegaly and Gigantism Drugs Production Growth Rate (2014-2019) Table Ipsen Acromegaly and Gigantism Drugs Production Market Share (2014-2019) Figure Ipsen Acromegaly and Gigantism Drugs Revenue Market Share (2014-2019) Table Ipsen Acromegaly and Gigantism Drugs Main Business and Markets Served Table Novartis Acromegaly and Gigantism Drugs Production Sites and Area Served Table Novartis Acromegaly and Gigantism Drugs Product Introduction, Application and Specification Table Novartis Acromegaly and Gigantism Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Acromegaly and Gigantism Drugs Production Growth Rate (2014-2019) Table Novartis Acromegaly and Gigantism Drugs Production Market Share (2014-2019) Figure Novartis Acromegaly and Gigantism Drugs Revenue Market Share (2014-2019) Table Novartis Acromegaly and Gigantism Drugs Main Business and Markets Served Table Pfizer Acromegaly and Gigantism Drugs Production Sites and Area Served Table Pfizer Acromegaly and Gigantism Drugs Product Introduction, Application and Specification Table Pfizer Acromegaly and Gigantism Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Acromegaly and Gigantism Drugs Production Growth Rate (2014-2019) Table Pfizer Acromegaly and Gigantism Drugs Production Market Share (2014-2019) Figure Pfizer Acromegaly and Gigantism Drugs Revenue Market Share (2014-2019) Table Pfizer Acromegaly and Gigantism Drugs Main Business and Markets Served Figure Global Acromegaly and Gigantism Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Acromegaly and Gigantism Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Acromegaly and Gigantism Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Acromegaly and Gigantism Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India Acromegaly and Gigantism Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Acromegaly and Gigantism Drugs by Type (2019-2025) Table Global Consumption (K Units) of Acromegaly and Gigantism Drugs by Application (2019-2025) Table Acromegaly and Gigantism Drugs Distributors List Table Acromegaly and Gigantism Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Ipsen Novartis Pfizer